Barth R H, Sodden S, Berlyne G M
Veterans Administration Medical Center, SUNY Health Science Center, Brooklyn 11209.
ASAIO Trans. 1989 Jul-Sep;35(3):597-600. doi: 10.1097/00002480-198907000-00139.
The low in vitro thrombogenicity of polyacrylonitrile (AN-69) membrane may offer the possibility of performing hemodialysis (HD) with little or no heparin. The authors sought to reduce heparin dosage using AN-69 dialyzers at blood flows of 400 to 600 ml/min. Over a 90 day period, 2228 HDs were performed: 1531 (69%) with AN-69, 528 (24%) with regenerated cellulose (RC), and 169 (8%) with cellulose acetate (CA) dialyzers. Two hundred and eighty-three HDs were performed without systemic heparin; blood compartments were prerinsed with 2,000 U heparin in 1,000 ml of 0.9% saline. Saline flushes were used in cases of rising venous drip chamber pressures or visible clotting. Incidence of clotting overall in AN-69 HDs was 0.52% (8/1531), 2.8% (15/528) with RC, and 11.2% (19/169) with CA. In heparin-free HDs, incidence with AN-69 was 1.3% (3/230), 28.6% with RC (4/14), and 25.6% with CA (10/39). AN-69 remained less thrombogenic when HDs were stratified by blood flow rate and vascular access was used. Urea clearance was no different in conventional and heparin-free treatments. Blood flow rates of 400 ml/min or higher had an independent antithrombogenic effect. It was concluded that the combination of high blood flow with AN-69 membrane allows marked reduction of HD heparin dose and safe routine use of heparin-free HD.
聚丙烯腈(AN - 69)膜的低体外血栓形成性可能为进行很少或不使用肝素的血液透析(HD)提供了可能性。作者试图在血流量为400至600 ml/min的情况下,使用AN - 69透析器减少肝素剂量。在90天的时间里,共进行了2228次血液透析:1531次(69%)使用AN - 69透析器,528次(24%)使用再生纤维素(RC)透析器,169次(8%)使用醋酸纤维素(CA)透析器。283次血液透析未使用全身肝素;血液腔室先用1000 ml 0.9%盐水中的2000 U肝素进行预冲洗。在静脉滴注室压力升高或出现可见凝血的情况下使用盐水冲洗。AN - 69血液透析中总体凝血发生率为0.52%(8/1531),RC为2.8%(15/528),CA为11.2%(19/169)。在无肝素血液透析中,AN - 69的发生率为1.3%(3/230),RC为28.6%(4/14),CA为25.6%(10/39)。当根据血流量分层并使用血管通路时,AN - 69的血栓形成性仍然较低。常规治疗和无肝素治疗的尿素清除率没有差异。400 ml/min或更高的血流量具有独立的抗血栓形成作用。得出的结论是,高血流量与AN - 69膜相结合可显著降低血液透析肝素剂量,并能安全地常规使用无肝素血液透析。